ATE498325T1 - Verwendung von probiotika und ballaststoffen bei diarrhö - Google Patents

Verwendung von probiotika und ballaststoffen bei diarrhö

Info

Publication number: ATE498325T1
Authority: AT; Austria
Prior art keywords: probiotics; diarrhea; fiber; diarrhoea; inulin
Prior art date: 2007-07-06

Application number

AT08766875T

Other languages

English (en)

Inventor

Jacques Bindels

Anna Christina Goedhart

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-06

Filing date

2008-07-04

Publication date

2011-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38522548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE498325(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-07-04 Application filed by Nutricia Nv filed Critical Nutricia Nv

2011-03-15 Application granted granted Critical

2011-03-15 Publication of ATE498325T1 publication Critical patent/ATE498325T1/de

Links

206010012735 Diarrhoea Diseases 0.000 title abstract 2
239000006041 probiotic Substances 0.000 title 1
235000018291 probiotics Nutrition 0.000 title 1
229920001202 Inulin Polymers 0.000 abstract 1
241000218588 Lactobacillus rhamnosus Species 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 1
229940029339 inulin Drugs 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
229920001282 polysaccharide Polymers 0.000 abstract 1
239000005017 polysaccharide Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Nutrition Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Botany (AREA)
Microbiology (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Chemical Or Physical Treatment Of Fibers (AREA)

AT08766875T 2007-07-06 2008-07-04 Verwendung von probiotika und ballaststoffen bei diarrhö ATE498325T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07111951		2007-07-06
PCT/NL2008/050454 WO2009008717A1 (en)	2007-07-06	2008-07-04	Use of probiotics and fibers for diarrhoea

Publications (1)

Publication Number	Publication Date
ATE498325T1 true ATE498325T1 (de)	2011-03-15

Family

ID=38522548

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08766875T ATE498325T1 (de)	2007-07-06	2008-07-04	Verwendung von probiotika und ballaststoffen bei diarrhö

Country Status (10)

Country	Link
US (1)	US20110014167A1 (de)
EP (1)	EP2173196B1 (de)
CN (1)	CN101772308B (de)
AT (1)	ATE498325T1 (de)
DE (1)	DE602008005025D1 (de)
ES (1)	ES2360573T3 (de)
PL (1)	PL2173196T3 (de)
PT (1)	PT2173196E (de)
RU (1)	RU2469558C2 (de)
WO (1)	WO2009008717A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080126195A1 (en)	2004-07-22	2008-05-29	Ritter Andrew J	Methods and Compositions for Treating Lactose Intolerance
SG10201901259RA (en)	2009-02-24	2019-03-28	Ritter Pharmaceuticals Inc	Prebiotic formulations and methods of use
US8785160B2 (en)	2009-02-24	2014-07-22	Ritter Pharmaceuticals, Inc.	Prebiotic formulations and methods of use
US9987306B2 (en) *	2012-10-15	2018-06-05	University Of Florida Research Foundation, Inc.	Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract
ITMI20131467A1 (it) *	2013-09-06	2015-03-07	Sofar Spa	Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
WO2015159125A1 (en) *	2014-04-15	2015-10-22	Compagnie Gervais Danone	Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after antibiotic dysbiosis
MA39710A (fr)	2014-04-23	2015-10-29	Sofar Spa	Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
IT201600083376A1 (it)	2016-08-08	2018-02-08	Sofar Spa	Uso di probiotici per aumentare l’assorbimento proteico
ITUA20164188A1 (it)	2016-06-08	2017-12-08	Sofar Spa	Nuovo uso medico di probiotici
IT201600122724A1 (it)	2016-12-02	2018-06-02	Sofar Spa	Exopolysaccharides and uses thereof
IT201600127498A1 (it)	2016-12-16	2018-06-16	Sofar Spa	Probiotici per uso nella diverticolosi e malattia diverticolare
RU2767400C2 (ru) *	2018-07-05	2022-03-17	Общество С Ограниченной Ответственностью "Валента - Интеллект"	Пробиотическая композиция для восстановления и поддержания сбалансированной микрофлоры кишечника у детей и младенцев и способ ее получения
JP7396798B2 (ja) *	2019-02-22	2023-12-12	帝人株式会社	腸内酪酸産生促進用組成物
US11751597B2 (en)	2019-11-05	2023-09-12	Alfasigma S.P.A.	Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
WO2022269539A1 (en) *	2021-06-23	2022-12-29	Danstar Ferment Ag	Method for favoring wellness and facilitating self-control before, during and/or after a restrictive diet
CN119488548B (zh) *	2024-09-12	2025-08-05	东北农业大学	一种用于缓解胃肠道腹泻的鼠李糖乳杆菌组合物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6241983B1 (en) *	1994-10-28	2001-06-05	Metagenics, Inc.	Bacteria-and fiber-containing composition for human gastrointestinal health
EP0904784A1 (de) *	1997-09-22	1999-03-31	N.V. Nutricia	Probiotisches Ernährungspräparat
EP1034787A1 (de) *	1999-03-11	2000-09-13	Société des Produits Nestlé S.A.	Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen
US20040161422A1 (en) *	1999-04-30	2004-08-19	Natarajan Ranganathan	Nutritional compositions comprising probiotics
US20040185032A1 (en) *	2003-03-18	2004-09-23	David Burrell	Compositions and methods for treating colic
JP4740866B2 (ja) *	2003-10-24	2011-08-03	ナムローゼフェンノートシャップニュートリシア	乳児向けシンバイオティック組成物
WO2006046871A2 (en) *	2004-10-29	2006-05-04	N.V. Nutricia	Peri-operative composition comprising lactobacillus rhamnosus
PL1855550T3 (pl) *	2005-02-28	2012-03-30	Nutricia Nv	Kompozycje żywieniowe z probiotykami
US20100233312A9 (en) *	2005-04-11	2010-09-16	The Procter & Gamble Company	Compositions comprising probiotic and sweetener components
EP1714660A1 (de) *	2005-04-21	2006-10-25	N.V. Nutricia	Uronsäure und Probiotika
CA2580591A1 (en) *	2006-03-03	2007-09-03	Health Beverage, Llc	Fiber containing alkaline beverage and methods for production thereof

2008
- 2008-07-04 US US12/667,898 patent/US20110014167A1/en not_active Abandoned
- 2008-07-04 AT AT08766875T patent/ATE498325T1/de not_active IP Right Cessation
- 2008-07-04 ES ES08766875T patent/ES2360573T3/es active Active
- 2008-07-04 EP EP08766875A patent/EP2173196B1/de not_active Revoked
- 2008-07-04 PL PL08766875T patent/PL2173196T3/pl unknown
- 2008-07-04 WO PCT/NL2008/050454 patent/WO2009008717A1/en not_active Ceased
- 2008-07-04 CN CN2008801015524A patent/CN101772308B/zh active Active
- 2008-07-04 PT PT08766875T patent/PT2173196E/pt unknown
- 2008-07-04 RU RU2010104008/13A patent/RU2469558C2/ru not_active IP Right Cessation
- 2008-07-04 DE DE602008005025T patent/DE602008005025D1/de active Active

Also Published As

Publication number	Publication date
ES2360573T3 (es)	2011-06-07
EP2173196B1 (de)	2011-02-16
RU2469558C2 (ru)	2012-12-20
PT2173196E (pt)	2011-05-23
PL2173196T3 (pl)	2011-06-30
WO2009008717A1 (en)	2009-01-15
RU2010104008A (ru)	2011-08-20
CN101772308A (zh)	2010-07-07
EP2173196A1 (de)	2010-04-14
DE602008005025D1 (de)	2011-03-31
CN101772308B (zh)	2013-08-28
US20110014167A1 (en)	2011-01-20

Legal Events

Date	Code	Title	Description
2011-08-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE602008005025D1 (de)	2011-03-31	Verwendung von probiotika und ballaststoffen bei diarrhö
BRPI1010637A2 (pt)	2019-04-02	suplementos nutricionais orais compreendendo probióticos
MX2012002402A (es)	2012-04-02	Bifidobacterium longum y trastornos gastrointestinales funcionales.
MX2009012255A (es)	2009-11-25	Probioticos en ambiente pre y/o postquirurgico.
NZ593708A (en)	2013-05-31	Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
MX2010001779A (es)	2010-07-06	Peptidos para vacunas.
MX2012005524A (es)	2013-04-03	Cepa de probioticos bifidobacterium.
CL2012001950A1 (es)	2013-01-11	Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
WO2009122042A3 (fr)	2009-11-26	Souche de lactobacillus rhamnosus
ATE537707T1 (de)	2012-01-15	Lactobacillus paracasei und gewichtskontrolle
WO2009130423A3 (fr)	2009-12-17	Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices
ZA200803819B (en)	2009-09-30	Probiotic Enterococci for improved immunity
MX337838B (es)	2016-03-22	Secuencias de repetidos palindromicos cortos regularmente intercalados agrupados de bifidobacterias.
PH12015500550A1 (en)	2016-06-13	Anti-notch1 nrr antibodies and methods using same
MX2009010418A (es)	2010-02-18	Cepas de bacterias bifidas probioticas.
MX2010006143A (es)	2010-07-06	Azolilmetiloxiranos, su uso y agentes que lo contienen.
MY173526A (en)	2020-01-31	Novel anti-?5?1 antibodies and uses thereof
WO2009077471A3 (de)	2010-02-25	Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
AU2019263623A8 (en)	2021-01-07	Probiotic Bifidobacterium breve strain and compositions comprising said strain
BRPI1010837A2 (pt)	2016-04-05	prevenção e tratamento de diarreia alérgica
ATE528012T1 (de)	2011-10-15	Uronsäure und probiotika
MX382895B (es)	2025-03-13	Suplemento dietético.
ATE514765T1 (de)	2011-07-15	Azeotropartige zusammensetzungen mit 1,1,1,2,3,3- hexafluor-3-methoxypropan und 1-brompropan
MX339753B (es)	2016-06-08	Composiciones vulcanizables basadas en cauchos de nitrilo que contienen grupos epoxi.
PH12019501629A1 (en)	2020-06-01	Probiotic compositions and uses therof